Source:http://linkedlifedata.com/resource/pubmed/id/16778090
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2006-6-16
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1078-0432
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3646-7
|
pubmed:dateRevised |
2008-6-2
|
pubmed:meshHeading |
pubmed-meshheading:16778090-Antibiotics, Antineoplastic,
pubmed-meshheading:16778090-Biological Markers,
pubmed-meshheading:16778090-Depsipeptides,
pubmed-meshheading:16778090-Heart,
pubmed-meshheading:16778090-Humans,
pubmed-meshheading:16778090-Myocardium,
pubmed-meshheading:16778090-Risk Management,
pubmed-meshheading:16778090-Ventricular Dysfunction, Left
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cardiac safety, risk management, and oncology drug development.
|
pubmed:publicationType |
Editorial,
Comment
|